1. Autoantibodies against P29ING4 are associated with complex regional pain syndrome

   • N. T. Baerlecken
   • R. Gaulke
   • M. Bernateck

   Original Article Open access 01 February 2020 Pages: 461 - 468

   

2. Retained or altered expression of major histocompatibility complex class I in patient-derived xenograft models in breast cancer

   • In Hye Song
   • Young-Ae Kim
   • Hee Jin Lee

   Original Article 03 January 2020 Pages: 469 - 477

   

3. A high-risk laboratory profile of antiphospholipid antibodies and thrombosis is associated with a large number of extra-criteria manifestations in obstetric antiphospholipid syndrome

   • Sebastián Udry
   • José Omar Latino
   • Gabriela de Larrañaga

   Original Article 23 December 2019 Pages: 478 - 485

   

4. CD226 attenuates Treg suppressive capacity via CTLA-4 and TIGIT during EAE

   • Ning Wang
   • Shuang Liang
   • Lihua Chen

   Original Article 09 January 2020 Pages: 486 - 496

   

5. Promotion on NLRC5 upregulating MHC-I expression by IFN-γ in MHC-I–deficient breast cancer cells

   • Ming-Zhen Zhao
   • Yu Sun
   • Li-Xin Sun

   Original Article 03 January 2020 Pages: 497 - 504

   

6. Blockade of TLR4 using TAK-242 (resatorvid) enhances anti-cancer effects of chemotherapeutic agents: a novel synergistic approach for breast and ovarian cancers

   • Bahareh Kashani
   • Zahra Zandi
   • Seyed H. Ghaffari

   Original Article 05 February 2020 Pages: 505 - 516